Redefining clinical trials in oncology and rare diseases across the Europe
Later this month, experts from the pharmaceutical and biotechnology industry and patient advocacy space will gather in Munich, Germany, to…
News
Solve Therapeutics raises $120m as MSD joins list of backers
Merus and Halozyme link on subcutaneous petosemtamab
Johnson & Johnson to acquire Halda Therapeutics for $3.05bn
Henlius and Organon score first US Perjeta biosimilar approval
High-dose Spinraza inches closer to EU approval despite FDA setback
Medicxi unveils €500m fund for asset-centric biotechs
FDA approves Sarepta’s updated Elevidys label for DMD
